WARSAW, Poland–(BUSINESS WIRE)– #biologics–Polpharma Biologics Group joint venture Bioeq has submitted a BLA for biosimilar Ranibizumab.
Category: Business
Glaukos Corporation Announces Second Quarter 2021 Financial Results
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced finan…
Ocular Therapeutix™ Announces Termination of the Collaboration with Regeneron to Develop a Sustained-Release Formulation of Aflibercept for the Treatment of Wet AMD and other Serious Retinal Diseases
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
Visus Therapeutics to Host First Capital Markets Day in New York City on August 31, 2021
SEATTLE–(BUSINESS WIRE)–Visus Therapeutics to host its First Capital Markets Day in New York City on August 31, 2021 from 10am to 2pm ET at Convene, 530 Fifth Avenue.
Eyevensys lève 12 millions de dollars dans un tour de table série B Plus
PARIS et CAMBRIDGE, Massachusetts–(BUSINESS WIRE)–Eyevensys, une société privée de biotechnologie au stade clinique qui développe des thérapies géniques non virales pour les maladies oculaires, annonce aujourd’hui qu’elle a levé 12 millions de dollar…
Iveric Bio to Participate in the 2021 Wedbush PacGrow Healthcare Virtual Conference on August 11, 2021
NEW YORK–(BUSINESS WIRE)–Iveric Bio announced that Pravin U. Dugel, M.D., President, will participate in a panel at the Wedbush Conference on Wed., Aug. 11 at 8:00 a.m. ET.
STAAR Surgical Reports Record Second Quarter Net Sales of $62.4 Million Up 77% Y/Y and Increases Outlook for 2021
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the second quarter ended …
Eyevensys Raises $12M in a Series B Plus Funding Round
PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)– #Eyevensys–Eyevensys, a private biotech developing gene therapies for ophthalmic diseases, today announces it has raised $12M in a Series B Plus funding round.
RightEye Launches Eye Care’s First Automated Sensorimotor Exam for Binocular Vision Testing
BETHESDA, Md.–(BUSINESS WIRE)–RightEye LLC, an advanced eye-tracking technology company, has launched the world’s first automated, quantitative sensorimotor exam system. RightEye Sensorimotor is an easy-to-use, all-in-one examination system that opto…
Iveric Bio Reports Second Quarter 2021 Operational Highlights and Financial Results
NEW YORK–(BUSINESS WIRE)–Iveric Bio announced financial and operating results for the quarter ended June 30, 2021 and provided a general business update.
Topcon Healthcare to Partner with RetInSight
OAKLAND, N.J.–(BUSINESS WIRE)– #TopconHealthcare–Topcon Healthcare of Oakland, NJ, a leading provider of medical devices and software solutions for the global eye care community, announced today that it will partner with RetInSight GmbH, a developer…
Worldwide Corneal Implants Industry to 2026 – North America Accounted for the Largest Share in the Global Market – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Corneal Implants Market- Growth, Trends, COVID-19 Impact and Forecasts (2021 – 2026)” report has been added to ResearchAndMarkets.com’s offering. The corneal implants market is projected to register a CAGR of more than 6% …
Fabrinet to Announce Fourth Quarter and Fiscal-Year 2021 Financial Results on August 16, 2021
BANGKOK–(BUSINESS WIRE)– #EarningsDate–Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, tod…
National Vision Holdings, Inc. Announces Second Quarter 2021 Earnings Release and Conference Call
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its second quarter 2021 financial results before the market opens on Thursday, August 12, 2021. The Company will host a conferen…
Global Graves' Ophthalmopathy Disease Clinical Trials Review: H1, 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Graves’ Ophthalmopathy Disease – Global Clinical Trials Review, H1, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. This report provides an overview of Graves’ Ophthalmopathy Clinical trials scen…
FDA Accepts Application for Genentech’s Faricimab for the Treatment of Wet Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME)
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA), under Pr…
Tesseract Health Names Diagnostics Innovator Dr. Vicky Demas CEO
GUILFORD, Conn.–(BUSINESS WIRE)–Tesseract Health Inc. has named industry veteran and entrepreneur Vasiliki (Vicky) Demas, Ph.D. as its Chief Executive Officer.
Ocular Hypertension Market Insight, Epidemiology and Market Forecast Report 2021-2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ocular Hypertension Market Insight, Epidemiology and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering. This ‘Ocular Hypertension – Market Insights, Epidemiology, and Market Forecast – 2030…
Global Contact Lens Markets Report 2021-2025 – Growing Smart Contact Lens Demand / Increased Consolidation of Market Players / Increasing Shift Towards Daily Lenses / Rising E-Commerce Sales – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Contact Lens Market: Insights & Forecast with Potential Impact of COVID-19 (2021-2025)” report has been added to ResearchAndMarkets.com’s offering. The global contact lens market is forecasted to reach US$11.02 …
Iveric Bio Completes Patient Enrollment of GATHER2 Pivotal Clinical Trial of Zimura® Ahead of Schedule
NEW YORK–(BUSINESS WIRE)–Iveric Bio announced the early completion of patient enrollment of GATHER2, the Company’s 2nd pivotal clinical trial of Zimura® (avacincaptad pegol).